These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18195150)

  • 21. Mitochondrial DNA depletion in progressive external ophthalmoplegia caused by POLG1 mutations.
    Tzoulis C; Papingji M; Fiskestrand T; Røste LS; Bindoff LA
    Acta Neurol Scand Suppl; 2009; (189):38-41. PubMed ID: 19566497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole exome sequencing identifies a homozygous POLG2 missense variant in an infant with fulminant hepatic failure and mitochondrial DNA depletion.
    Varma H; Faust PL; Iglesias AD; Lagana SM; Wou K; Hirano M; DiMauro S; Mansukani MM; Hoff KE; Nagy PL; Copeland WC; Naini AB
    Eur J Med Genet; 2016 Oct; 59(10):540-5. PubMed ID: 27592148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple mtDNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogeneses.
    Carrozzo R; Hirano M; Fromenty B; Casali C; Santorelli FM; Bonilla E; DiMauro S; Schon EA; Miranda AF
    Neurology; 1998 Jan; 50(1):99-106. PubMed ID: 9443465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic analysis of two Japanese families with progressive external ophthalmoplegia and parkinsonism.
    Sato K; Yabe I; Yaguchi H; Nakano F; Kunieda Y; Saitoh S; Sasaki H
    J Neurol; 2011 Jul; 258(7):1327-32. PubMed ID: 21301859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic progressive external ophthalmoplegia with ragged-red fibers: clinical, morphological and genetic investigations in 43 patients.
    Laforêt P; Lombès A; Eymard B; Danan C; Chevallay M; Rouche A; Frachon P; Fardeau M
    Neuromuscul Disord; 1995 Sep; 5(5):399-413. PubMed ID: 7496174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2.
    Walter MC; Czermin B; Muller-Ziermann S; Bulst S; Stewart JD; Hudson G; Schneiderat P; Abicht A; Holinski-Feder E; Lochmüller H; Chinnery PF; Klopstock T; Horvath R
    J Neurol; 2010 Sep; 257(9):1517-23. PubMed ID: 20405137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes.
    Amati-Bonneau P; Valentino ML; Reynier P; Gallardo ME; Bornstein B; Boissière A; Campos Y; Rivera H; de la Aleja JG; Carroccia R; Iommarini L; Labauge P; Figarella-Branger D; Marcorelles P; Furby A; Beauvais K; Letournel F; Liguori R; La Morgia C; Montagna P; Liguori M; Zanna C; Rugolo M; Cossarizza A; Wissinger B; Verny C; Schwarzenbacher R; Martín MA; Arenas J; Ayuso C; Garesse R; Lenaers G; Bonneau D; Carelli V
    Brain; 2008 Feb; 131(Pt 2):338-51. PubMed ID: 18158317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensory ataxic neuropathy with dysarthria and ophthalmoparesis (SANDO) in late life due to compound heterozygous POLG mutations.
    Weiss MD; Saneto RP
    Muscle Nerve; 2010 Jun; 41(6):882-5. PubMed ID: 20513108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient homozygous for a recessive POLG mutation presents with features of MERRF.
    Van Goethem G; Mercelis R; Löfgren A; Seneca S; Ceuterick C; Martin JJ; Van Broeckhoven C
    Neurology; 2003 Dec; 61(12):1811-3. PubMed ID: 14694057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.
    Luoma P; Melberg A; Rinne JO; Kaukonen JA; Nupponen NN; Chalmers RM; Oldfors A; Rautakorpi I; Peltonen L; Majamaa K; Somer H; Suomalainen A
    Lancet; 2004 Sep 4-10; 364(9437):875-82. PubMed ID: 15351195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. POLG mutations causing ophthalmoplegia, sensorimotor polyneuropathy, ataxia, and deafness.
    Mancuso M; Filosto M; Bellan M; Liguori R; Montagna P; Baruzzi A; DiMauro S; Carelli V
    Neurology; 2004 Jan; 62(2):316-8. PubMed ID: 14745080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Encephalomyopathies caused by abnormal nuclear-mitochondrial intergenomic cross-talk.
    Lamperti C; Zeviani M
    Acta Myol; 2009 Jul; 28(1):2-11. PubMed ID: 19772189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr?
    Neeve VC; Samuels DC; Bindoff LA; van den Bosch B; Van Goethem G; Smeets H; Lombès A; Jardel C; Hirano M; Dimauro S; De Vries M; Smeitink J; Smits BW; de Coo IF; Saft C; Klopstock T; Keiling BC; Czermin B; Abicht A; Lochmüller H; Hudson G; Gorman GG; Turnbull DM; Taylor RW; Holinski-Feder E; Chinnery PF; Horvath R
    Brain; 2012 Dec; 135(Pt 12):3614-26. PubMed ID: 23250882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO).
    Agostino A; Valletta L; Chinnery PF; Ferrari G; Carrara F; Taylor RW; Schaefer AM; Turnbull DM; Tiranti V; Zeviani M
    Neurology; 2003 Apr; 60(8):1354-6. PubMed ID: 12707443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a novel heterozygous guanosine monophosphate reductase (GMPR) variant in a patient with a late-onset disorder of mitochondrial DNA maintenance.
    Sommerville EW; Dalla Rosa I; Rosenberg MM; Bruni F; Thompson K; Rocha M; Blakely EL; He L; Falkous G; Schaefer AM; Yu-Wai-Man P; Chinnery PF; Hedstrom L; Spinazzola A; Taylor RW; Gorman GS
    Clin Genet; 2020 Feb; 97(2):276-286. PubMed ID: 31600844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mutation in spacer region of POLG associated with ataxia neuropathy spectrum and gastroparesis.
    Bostan A; Glibert G; Dachy B; Dan B
    Auton Neurosci; 2012 Sep; 170(1-2):70-2. PubMed ID: 22805437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the human homozygous R182W POLG2 mutation in mitochondrial DNA depletion syndrome.
    Hoff KE; DeBalsi KL; Sanchez-Quintero MJ; Longley MJ; Hirano M; Naini AB; Copeland WC
    PLoS One; 2018; 13(8):e0203198. PubMed ID: 30157269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new POLG1 mutation with peo and severe axonal and demyelinating sensory-motor neuropathy.
    Santoro L; Manganelli F; Lanzillo R; Tessa A; Barbieri F; Pierelli F; Di Giacinto G; Nigro V; Santorelli FM
    J Neurol; 2006 Jul; 253(7):869-74. PubMed ID: 16715201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic Effects of the
    DeBalsi KL; Longley MJ; Hoff KE; Copeland WC
    J Biol Chem; 2017 Mar; 292(10):4198-4209. PubMed ID: 28154168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autosomal dominant external ophthalmoplegia and bipolar affective disorder associated with a mutation in the ANT1 gene.
    Siciliano G; Tessa A; Petrini S; Mancuso M; Bruno C; Grieco GS; Malandrini A; DeFlorio L; Martini B; Federico A; Nappi G; Santorelli FM; Murri L
    Neuromuscul Disord; 2003 Feb; 13(2):162-5. PubMed ID: 12565915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.